| Financial Year |
March 31 2022 |
| Monetary Funds |
190,460,290.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
28,459,101.33 |
| Advances to Suppliers |
38,370,273.74 |
| Other Receivables |
2,295,349.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
176,551,873.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,787,282.21 |
| Total Current Assets |
498,835,800.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
837,336.81 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
533,004,144.20 |
| Under-construction Projects |
10,666,706.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
94,241,296.45 |
| R&D expenses |
-- |
| Goodwill |
210,016,574.07 |
| Long-Term Deferred and Prepaid Expenses |
35,901.31 |
| Deferred Income Tax Assets |
759,663.14 |
| Other Non-Current Assets |
15,933,596.18 |
| Sub-Total of Non-Current Assets |
865,570,652.11 |
| Total Assets |
1,364,406,452.45 |
| Short-Term Loans |
241,435,520.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
62,436,768.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,009,106.31 |
| Taxes Payable |
7,575,622.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,176,918.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
57,706,824.17 |
| Other Current Liabilities |
2,979,909.93 |
| Sub-Total of Current Liabilities |
461,493,283.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
732,009,267.98 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,571,454.18 |
| Deferred Income Tax Liabilities |
6,164,208.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
752,566,251.73 |
| Total Liabilities |
1,214,059,534.92 |
| Paid-In Capital(Or Share Stock) |
1,071,274,605.00 |
| Capital Surplus |
882,549,887.15 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,673,846,421.18 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
150,346,917.53 |
| Owner's Equity（Stockholder's Equity） |
150,346,917.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,364,406,452.45 |
